GoodRx (GDRX) director exercises 192K options and gifts 150K Class A shares

Rhea-AI Filing Summary

GoodRx Holdings, Inc. director Agnes Rey-Giraud exercised stock options to acquire 192,185 shares of Class A common stock at $0.47 per share. On the same date, she made bona fide gifts totaling 150,438 shares, including 75,219 shares transferred to a family trust for which she is the sole trustee and beneficiary. Following these transactions, she continues to hold a substantial direct position in GoodRx stock.

Insider Trade Summary

192,185 shares exercised/converted

Mixed 4 txns

Insider REY-GIRAUD AGNES

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	192,185	$0.00	--
Exercise	Class A Common Stock	192,185	$0.47	$90K
Gift	Class A Common Stock	75,219	$0.00	--
Gift	Class A Common Stock	75,219	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Class A Common Stock — 277,633 shares (Direct); Class A Common Stock — 0 shares (Indirect, By ARG Family Legacy Trust #1)

Footnotes (1)

1. On March 12, 2026, the Reporting Person transferred 75,219 shares of Class A common stock to the Agnes Rey-Giruad Trust DTD 09/13/2002 RST 12/10/2012 (the "Trust"). The Reporting Person serves as the sole trustee and sole beneficiary of the Trust. The option is fully vested and exercisable.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

REY-GIRAUD AGNES

(Last) (First) (Middle)

C/O GOODRX HOLDINGS, INC.

2701 OLYMPIC BOULEVARD

(Street)

SANTA MONICA CA 90404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/12/2026		M		192,185	A	$0.47	277,633	D
Class A Common Stock	03/12/2026		G		75,219(1)	D	$0	0	I	By ARG Family Legacy Trust #1
Class A Common Stock	03/12/2026		G		75,219(1)	A	$0	352,852	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.47	03/12/2026		M			192,185	(2)	11/16/2026	Class A Common Stock	192,185	$0	0	D

Explanation of Responses:

1. On March 12, 2026, the Reporting Person transferred 75,219 shares of Class A common stock to the Agnes Rey-Giruad Trust DTD 09/13/2002 RST 12/10/2012 (the "Trust"). The Reporting Person serves as the sole trustee and sole beneficiary of the Trust.

2. The option is fully vested and exercisable.

Remarks:

	/s/ Gracye Cheng, Attorney-in-Fact for Agnes Rey-Giraud	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Agnes Rey-Giraud report at GoodRx (GDRX)?

Agnes Rey-Giraud reported exercising stock options for 192,185 Class A shares at $0.47 per share and making bona fide gifts totaling 150,438 shares. These transactions combine a routine option exercise with personal share transfers, not open-market buying or selling.

Did the GoodRx (GDRX) director buy or sell shares on the open market?

The filing shows no open-market purchases or sales. Rey-Giraud exercised stock options to receive shares and then transferred 150,438 shares as bona fide gifts, including a transfer to her family trust, rather than trading in the public market.

How many GoodRx (GDRX) options did Agnes Rey-Giraud exercise?

She exercised a stock option covering 192,185 shares of Class A common stock at an exercise price of $0.47 per share. The filing notes that the option was fully vested and exercisable at the time of the transaction on March 12, 2026.

What share gifts did the GoodRx (GDRX) director report?

Rey-Giraud reported bona fide gifts totaling 150,438 shares of Class A common stock. This includes 75,219 shares transferred to the Agnes Rey-Giraud Trust, where she is the sole trustee and sole beneficiary, plus an additional 75,219 shares recorded as a direct-position gift entry.

What role does the Agnes Rey-Giraud Trust play in the GoodRx (GDRX) filing?

The filing states that 75,219 shares of Class A common stock were transferred to the Agnes Rey-Giraud Trust. Rey-Giraud is described as the sole trustee and sole beneficiary of this trust, meaning she continues to control and benefit from those transferred shares.

How many GoodRx (GDRX) shares does Agnes Rey-Giraud hold after these transactions?

After the reported transactions, one line in the filing shows Rey-Giraud with 352,852 Class A shares held directly. Another line shows 0 shares indirectly in the trust entry, while the footnote clarifies she is trustee and beneficiary of the trust receiving 75,219 shares.